Clinical trial dropout rates are quietly eating through research budgets and delaying breakthroughs that patients are waiting for. Up to 85% of clinical trials fail to retain enough participants to meet their targets, and roughly 30% of enrolled participants drop out before a trial finishes. Every lost participant means rework, budget overruns, and in some cases, a trial that never delivers results.
Key Takeaways
- Up to 85% of clinical trials fail to retain enough participants to complete on time.
- Replacing one lost participant costs nearly three times the original recruitment investment.
- Slow or unreliable payment is a controllable retention factor that sponsors often overlook.
- Real-time digital disbursements reduce friction and keep participants engaged through completion.
- Modernizing participant payment processes is one of the most direct ways to reduce attrition and protect trial completion.
The State of Clinical Trial Retention in 2026
More than 80% of clinical trials fail to enroll on time, and about two-thirds miss their original targets entirely. Clinical trial dropout rates have stayed stubbornly high across most therapeutic areas, and the downstream effects are real.
Every delayed start chips away at a trial’s scientific validity. More telling: 55% of terminated trials cite low accrual as the primary reason for shutdown. That’s a retention problem, happening inside trials that were already funded, staffed, and launched.
The Real Cost of a Lost Participant
The cost of clinical trial dropout is staggering when you put numbers to it. According to the Tufts Center for the Study of Drug Development, recruiting one participant costs $6,533 on average. Replacing someone who drops out costs $19,533, nearly three times the original investment, just to get back to square one.
The cost compounds in later phases. Phase 2 losses run $30,000 to $70,000 per patient. Phase 3 reaches $75,000 to $150,000 or more. Multiply that across even a small number of dropouts, and the financial case for investing in retention becomes obvious.
Top Reasons Participants Drop Out of Clinical Trials
Understanding why participants drop out of clinical trials means distinguishing between what sponsors can’t control and what they can. Difficult schedules, worsening health, and loss of interest are the obvious culprits. But financial barriers in clinical trials consistently rank among the top drivers of disengagement, and unlike health changes or scheduling conflicts, payment friction is fixable.
Research from the Association of Clinical Research Professionals identifies compensation, transparency, and convenience as the most frequently cited retention factors. Clinical trial retention strategies that ignore the payment experience are missing a major lever.
When compensation is slow, unreliable, or hard to access, it signals to participants that their time isn’t valued, and eventually some stop showing up. Effective participant retention strategies treat payment as a core part of the participant experience, not an afterthought.
The Payment Problem Sponsors Don’t Talk About
Most sponsors invest heavily in recruitment and protocol design, but participant payment often runs on outdated infrastructure. Paper checks get lost. Batch gift cards arrive late.
ACH transfers take three to five business days, which means a participant who completes a visit on Thursday might not see reimbursement until the following week. That gap matters more than sponsors tend to think.
A high clinical trial dropout rate is often a symptom of this friction. The challenge of paying research participants at scale also creates operational drag for site coordinators, who end up fielding calls about missing checks instead of supporting participants. Inconsistent disbursements also add compliance risk; sponsors need a payment record that’s clean, timestamped, and tied to visit milestones.
Organizations ready to fix this can see how Rellevate’s disbursement solutions for clinical research eliminate the delays and manual steps that erode participant trust.
How to Reduce Dropout Through Better Payment Experience
Improving the payment experience is one of the most direct levers sponsors have for improving retention. It doesn’t require a protocol amendment or a site retraining effort. It means switching from a slow, manual disbursement process to one that delivers compensation the moment a participant completes a visit or hits a milestone.
When participants receive payment through digital wallets or prepaid cards in real time, the experience shifts. No uncertainty about when funds arrive. No lost checks to chase. That reliability builds trust, and trust keeps people enrolled.
Smarter clinical trial payments also reduce coordinator workload, freeing up staff to focus on participant support rather than payment troubleshooting.
Best Practices for Participant Payment in 2026
The most effective healthcare disbursement programs in clinical research are fast, trackable, and flexible. These are the practices sponsors and site teams should prioritize:
- Use real-time digital disbursements tied to visit completion so participants receive payment the same day they show up.
- Offer digital wallet and prepaid card options to serve both banked and underbanked participant populations.
- Automate reconciliation so every disbursement is documented, timestamped, and audit-ready without manual input.
- Communicate payment timelines clearly during onboarding so participants know exactly what to expect and when.
- Choose a disbursement platform that integrates with your trial management system to reduce coordinator workload.
Sponsors ready to cut attrition from the payment side can see how Rellevate simplifies participant compensation in clinical settings and what that means for trial completion rates.
The Bottom Line
Clinical trial dropout rates won’t drop on their own, but payment friction is one problem sponsors can actually solve. Rellevate delivers real-time disbursements via digital wallets and prepaid cards, with built-in automated reconciliation. No waiting, no lost checks, no manual processing.
Instead of participants waiting on payments, payments are ready when they are. That is a modern payment experience that gives participants one less reason to walk away and gives sponsors a clearer path to finishing trials on time and on budget
